Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anaplastic large cell lymphoma: a clinicopathologic analysis.

B F Skinnider1, J M Connors, S B Sutcliffe

  • 1Department of Pathology, British Columbia Cancer Agency, Vancouver, Canada.

Hematological Oncology
|March 22, 2000
PubMed
Summary

Anaplastic large cell lymphoma (ALCL) classification is improved by identifying distinct subtypes. Detecting the NPM-ALK fusion protein aids in distinguishing ALCL subtypes with different prognoses, crucial for patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis.

Journal de medecine vasculaire·2022
Same author

Cancer and thrombosis: new insights to an old problem.

Journal de medecine vasculaire·2020
Same author

Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis.

Journal de medecine vasculaire·2020
Same author

New progress in the treatment and prophylaxis of venous thrombo-embolism in cancer patients.

Journal de medecine vasculaire·2020
Same author

Hodgkin lymphoma, treatment and thrombosis: a dangerous mix.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Observation as the initial management strategy in patients with mantle cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Anaplastic large cell lymphoma (ALCL) is a heterogeneous group of T-cell lymphomas.
  • Histologic examination alone is insufficient for accurate prognostication in ALCL.
  • Distinguishing ALCL subtypes is critical for determining appropriate patient management and predicting outcomes.

Purpose of the Study:

  • To review the clinicopathologic features of ALCL.
  • To highlight the importance of integrating clinical, phenotypic, and genotypic data for ALCL classification.
  • To emphasize the diagnostic and prognostic significance of the t(2;5) translocation and NPM-ALK fusion protein.

Main Methods:

  • Review of existing literature on ALCL clinicopathologic features.
  • Discussion of diagnostic methods including immunohistochemistry for ALK protein detection.

Related Experiment Videos

  • Correlation of genetic findings (t(2;5) translocation) with clinical presentation and prognosis.

    • Main Results:

    • Several distinct clinicopathologic entities within ALCL have been identified.
    • A subset of ALCL is characterized by the t(2;5) translocation, leading to the NPM-ALK fusion protein.
    • Detection of ALK protein is a key marker for a distinct ALCL biologic entity with significant prognostic implications.

    Conclusions:

    • The identification of ALK-positive ALCL represents a significant advancement in understanding ALCL heterogeneity.
    • ALK-negative ALCL generally carries a poorer prognosis compared to ALK-positive ALCL.
    • Primary cutaneous ALCL has an excellent prognosis and should be differentiated from systemic ALCL subtypes.